Literature DB >> 21967022

Prevalence, awareness, treatment, and control of hypertension among adults in Beijing, China.

Li Cai1, Aiping Liu, Lei Zhang, Shuping Li, Peiyu Wang.   

Abstract

Hypertension is an important modifiable risk factor for cardiovascular diseases. This study aimed to determine the up-to-date prevalence, awareness, treatment, and control of hypertension, and their related influencing factors in adults in Beijing, China. A cross-sectional study was conducted in 2008. A total of 5760 adults aged 18-79 years were selected from the general population. Data from a standardized questionnaire, physical examination, and blood sample were obtained. The prevalence of hypertension was 35.5% (41.8% in men, 30.9% in women) and increased with age in both sexes. The prevalence was similarly high in urban (35.6%) and in rural (34.9%) areas. Body mass index (BMI) and waist circumference were independently associated with hypertension. Participants with diabetes and/or dyslipidemia had higher prevalence of hypertension than their counterparts. Among hypertensive patients, 42.5% were aware of the diagnosis, 35.9% received treatment, and 11.8% had hypertension control. Awareness and treatment of hypertension were low in men, young people, and rural residents. Control of hypertension was lower in older people and those with lower educational attainment. High waist circumference (central obesity) resulted in low control of hypertension (odds ratio = 0.45). Our findings underscore the urgent need to develop a comprehensive health strategy for the prevention, detection, and control of hypertension to avert the cardiovascular disease epidemic in Beijing.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21967022     DOI: 10.3109/10641963.2011.618206

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  25 in total

Review 1.  Prevalence and characteristics of hypertension in mainland Chinese adults over decades: a systematic review.

Authors:  L Fang; J Song; Z Ma; L Zhang; C Jing; D Chen
Journal:  J Hum Hypertens       Date:  2014-02-27       Impact factor: 3.012

2.  Trends of hypertension prevalence, awareness, treatment and control in rural areas of northern China during 1991-2011.

Authors:  J Wang; X Ning; L Yang; H Lu; J Tu; W Jin; W Zhang; T-C Su
Journal:  J Hum Hypertens       Date:  2013-06-06       Impact factor: 3.012

3.  Prevalence, incidence, awareness and control of hypertension in the province of Quebec: perspective from administrative and survey data.

Authors:  Claudia Blais; Louis Rochette; Denis Hamel; Paul Poirier
Journal:  Can J Public Health       Date:  2014-02-03

4.  Application of a novel hybrid algorithm of Bayesian network in the study of hyperlipidemia related factors: a cross-sectional study.

Authors:  Xuchun Wang; Jinhua Pan; Zeping Ren; Mengmeng Zhai; Zhuang Zhang; Hao Ren; Weimei Song; Yuling He; Chenglian Li; Xiaojuan Yang; Meichen Li; Dichen Quan; Limin Chen; Lixia Qiu
Journal:  BMC Public Health       Date:  2021-07-12       Impact factor: 3.295

5.  Factors associated with prevalence, awareness, treatment and control of hypertension among adults in Southern China: a community-based, cross-sectional survey.

Authors:  Hao Wang; Xinwei Zhang; Jie Zhang; Qingfang He; Ruying Hu; Lixin Wang; Danting Su; Yuanyuan Xiao; Jin Pan; Zhen Ye
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

6.  Is yangxue qingnao granule combined with antihypertensive drugs, a new integrative medicine therapy, more effective than antihypertensive therapy alone in treating essential hypertension?

Authors:  Jie Wang; Xiaochen Yang; Bo Feng; Weidong Qian; Zhuyuan Fang; Wei Liu; Haixia Li; Xiaoke Li; Fuyong Chu; Xingjiang Xiong
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-21       Impact factor: 2.629

Review 7.  A systematic review of recent clinical practice guidelines on the diagnosis, assessment and management of hypertension.

Authors:  Lubna A Al-Ansary; Andrea C Tricco; Yaser Adi; Ghada Bawazeer; Laure Perrier; Mohammed Al-Ghonaim; Nada AlYousefi; Mariam Tashkandi; Sharon E Straus
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

8.  Trends in Prevalence, Awareness, Treatment and Control of Hypertension during 2001-2010 in an Urban Elderly Population of China.

Authors:  Lei Wu; Yao He; Bin Jiang; Dongling Sun; Jianhua Wang; Miao Liu; Shanshan Yang; Yiyan Wang
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

9.  Developing an appropriate model for self-care of hypertensive patients: first experience from EMRO.

Authors:  Masoumeh Sadeghi; Mansoor Shiri; Hamidreza Roohafza; Fatemeh Rakhshani; Sadaf Sepanlou; Nizal Sarrafzadegan
Journal:  ARYA Atheroscler       Date:  2013-06

Review 10.  A review of the efficacy and tolerability of combination amlodipine/valsartan in non-white patients with hypertension.

Authors:  Keith C Ferdinand; Samar A Nasser
Journal:  Am J Cardiovasc Drugs       Date:  2013-10       Impact factor: 3.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.